phosphorylcholine has been researched along with B16 Melanoma in 6 studies
Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated mechanisms for inhibition of B16 melanoma cell migration and invasion by sphingosine-1-phosphate (S1P), which is the ligand for the Edg family G protein-coupled receptors and also implicated as an intracellular second messenger." | 3.72 | Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity. ( Arikawa, K; Kitayama, J; Nagawa, H; Sugimoto, N; Takehara, K; Takuwa, N; Takuwa, Y; Yamaguchi, H, 2003) |
| "Therefore, cystemustine-treated B16 melanoma tumors acquire a new Plp metabolism phenotype, a mechanism that could participate in tumor cell redifferentiation and/or survival." | 1.31 | Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples. ( De Latour, M; Demidem, A; Madelmont, JC; Morvan, D; Papon, J, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Battogtokh, G | 1 |
| Ko, YT | 1 |
| Arikawa, K | 1 |
| Takuwa, N | 1 |
| Yamaguchi, H | 1 |
| Sugimoto, N | 1 |
| Kitayama, J | 1 |
| Nagawa, H | 1 |
| Takehara, K | 1 |
| Takuwa, Y | 1 |
| Morvan, D | 2 |
| Demidem, A | 2 |
| Madelmont, JC | 2 |
| Degani, H | 1 |
| DeJordy, JO | 1 |
| Salomon, Y | 1 |
| Papon, J | 1 |
| De Latour, M | 1 |
| Zeisig, R | 1 |
| Fichtner, I | 1 |
| Arndt, D | 1 |
| Jungmann, S | 1 |
6 other studies available for phosphorylcholine and B16 Melanoma
| Article | Year |
|---|---|
Self-assembling micelle-like nanoparticles with detachable envelopes for enhanced delivery of nucleic acid therapeutics.
Topics: Animals; Gene Transfer Techniques; Hydrogen-Ion Concentration; Male; Melanoma, Experimental; Mice; M | 2014 |
Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.
Topics: Adenoviridae; Animals; Blotting, Northern; Blotting, Western; Calcium; Cell Movement; CHO Cells; Cri | 2003 |
Response of melanoma tumor phospholipid metabolism to chloroethyle nitrosourea: a high resolution proton NMR spectroscopy study.
Topics: Animals; Antineoplastic Agents; Cell Survival; Ethanolamines; Glycerylphosphorylcholine; Magnetic Re | 2003 |
Determination of the response of melanoma cells to melanocyte stimulating hormone by 31P nuclear magnetic resonance spectroscopy.
Topics: 1-Methyl-3-isobutylxanthine; Animals; Colforsin; Cyclic AMP; Ethanolamines; Magnetic Resonance Spect | 1993 |
Melanoma tumors acquire a new phospholipid metabolism phenotype under cystemustine as revealed by high-resolution magic angle spinning proton nuclear magnetic resonance spectroscopy of intact tumor samples.
Topics: Animals; Antineoplastic Agents; Cell Division; Choline; Ethanolamines; Male; Melanoma, Experimental; | 2002 |
Antitumor effects of alkylphosphocholines in different murine tumor models: use of liposomal preparations.
Topics: Animals; Antineoplastic Agents; Hemolysis; Humans; Leukemia P388; Liposomes; Mammary Neoplasms, Expe | 1991 |